Lv31
340 积分 2023-11-02 加入
Binding sites and design strategies for small molecule GLP-1R Agonists
3小时前
待确认
Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat
20天前
已完结
Mechanisms of Polymyxin Resistance
20天前
已完结
In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates
28天前
已完结
In complicated UTIs, cefepime–taniborbactam increased treatment success vs. meropenem at 19 to 23 d
28天前
已完结
Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales
28天前
已完结
Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain
28天前
已完结
Pharmacodynamics of taniborbactam in combination with cefepime studied in an in vitro model of infection
28天前
已完结
Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
28天前
已完结
[Expert Consensus on Obesity Prevention and Treatment in China]
1个月前
已完结
皖公网安备34019202002308
